12th Biosimilars Congregation 2018
View: 134
Website http://www.virtueinsight.com/pharma/12th-Biosimilars-Congregation-2018/ |
Edit Freely
Category Conference;pharma;biosimilars
Deadline: February 27, 2018 | Date: February 27, 2018-February 28, 2018
Venue/Country: London, U.K.
Updated: 2017-12-13 18:31:36 (GMT+9)
Call For Papers - CFP
12th Biosimilars Congregation 2018 will provide insight into the current state of play in the EU and stimulate debate, in a multi-stakeholder setting, on the vital role of biosimilar medicines in the sustainability of healthcare systems. KEY SPEAKERS:Boehringer Ingelheim, Teva Pharmaceuticals, Fresenius Kabi SwissBioSim, Takeda, Wockhardt, Glenmark, Lupin, BPCRCS, GE Healthcare, European Medicines Agency, Bioceros, Danish Generic and Biosimilar Medicines Industry Association (IGL), ValeriusBio, ZRx Outcomes Research , Norwegian Medicines Agency, NICE, Polpharma Biologics, NHS - NIHR Clinical Research Network, Sterne, Kessler, Goldstein & Fox , Generics Bulletin, Frontline Pharma Consulting, Purple Squirrel Economics ,Bristows, Arnold & PorterKEY THEMES:-Brexit and Biosimilars, Biosimilar strategies , Current market trends ,Biosimilars in Oncology, Current challenges and opportunities , Payer perspective, Biosimilar Interchangeability, CMC, Preclinical and clinical considerations , Impact of Technology, Gain in-depth knowledge on role of technology transfer , Impact on clinical practice, Production of biosimilar MAbs, Right investments & potentials, Latest developments in regulation ,WHO SHOULD ATTEND:People fromBiopharmaceuticals/ Biotherapeutics, Follow on Biologics/Follow on Proteins/Biosimilars, Biologics/Biotechnology/ Biogenerics, Legal Affairs , Intellectual Property, Health Economics, Pricing and Reimbursement, Clinical Immunology, Principal Scientist, Chief Scientific Officer, Process Control and Analytical Technologies, Analytical Characterisation, Regulatory Compliance, Risk Management, Quality Affairs/ Quality Control, New Product Development, Process Science, Portfolio Management, Research & Development, Business Operations, Scientific Affairs, Commercial Affairs, Marketing.Join this event which provides an important platform for Biosimilars stakeholders to discuss and share best practices in furthering Biosimilars development.
Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.